Come up with a name for your new list and we'll add to it:
SuppreMol was acquired by
Baxter International on March 04, 2015.
SuppreMol is a privately held biopharmaceutical company developing therapeutics for the treatment of autoimmune and allergic diseases. The company is pioneering the development of soluble Fc-gamma rec…